Tap Consulting, LLC Merck & Co., Inc. Transaction History

Tap Consulting, LLC

$487 Million
Q3 2024

A detailed history of Tap Consulting, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Tap Consulting, LLC holds 2,385 shares of MRK stock, worth $233,849. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,385

Previous 2,310 3.25%

Holding current value

$233,849

Previous $285,000 5.26%

% of portfolio

0.06%

Previous 0.06%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	BUY	$111.15 - $128.97 $8,336 - $9,672	75 Added 3.25%	2,385 $270,000
Q2 2024 Aug 06, 2024	BUY	$123.8 - $132.96 $12,132 - $13,030	98 Added 4.43%	2,310 $285,000
Q1 2024 Apr 22, 2024	BUY	$113.24 - $131.95 $16,419 - $19,132	145 Added 7.01%	2,212 $291,000
Q4 2023 Feb 02, 2024	BUY	$100.18 - $109.02 $207,072 - $225,344	2,067 New	2,067 $225,000
Q2 2023 Jul 19, 2023	BUY	$108.61 - $118.38 $977 - $1,065	9 Added 0.15%	6,146 $709,000
Q1 2023 Apr 18, 2023	SELL	$102.94 - $114.86 $143,601 - $160,229	-1,395 Reduced 18.52%	6,137 $652,000
Q4 2022 Jan 23, 2023	BUY	$87.44 - $112.11 $10,580 - $13,565	121 Added 1.63%	7,532 $0
Q3 2022 Oct 12, 2022	BUY	$84.53 - $94.96 $6,424 - $7,216	76 Added 1.04%	7,411 $638,000
Q2 2022 Jul 26, 2022	SELL	$83.49 - $94.64 $40,826 - $46,278	-489 Reduced 6.25%	7,335 $669,000
Q1 2022 Apr 26, 2022	SELL	$73.51 - $82.4 $51,971 - $58,256	-707 Reduced 8.29%	7,824 $642,000
Q4 2021 Jan 27, 2022	BUY	$72.28 - $90.54 $1,879 - $2,354	26 Added 0.31%	8,531 $654,000
Q3 2021 Nov 03, 2021	SELL	$71.68 - $78.83 $1,290 - $1,418	-18 Reduced 0.21%	8,505 $639,000
Q2 2021 Aug 06, 2021	SELL	$70.31 - $77.77 $10,968 - $12,132	-156 Reduced 1.8%	8,523 $663,000
Q1 2021 May 12, 2021	BUY	$68.86 - $81.11 $36,426 - $42,907	529 Added 6.49%	8,679 $669,000
Q4 2020 Jan 19, 2021	BUY	$71.77 - $79.65 $4,593 - $5,097	64 Added 0.79%	8,150 $667,000
Q3 2020 Oct 20, 2020	SELL	$73.18 - $82.95 $731 - $829	-10 Reduced 0.12%	8,086 $671,000
Q2 2020 Aug 11, 2020	BUY	$70.42 - $80.13 $4,858 - $5,528	69 Added 0.86%	8,096 $626,000
Q1 2020 Apr 29, 2020	BUY	$63.36 - $87.82 $950 - $1,317	15 Added 0.19%	8,027 $618,000
Q4 2019 Jan 27, 2020	SELL	$77.58 - $87.54 $6,516 - $7,353	-84 Reduced 1.04%	8,012 $729,000
Q3 2019 Nov 08, 2019	BUY	$76.08 - $82.93 $15,292 - $16,668	201 Added 2.55%	8,096 $681,000
Q1 2019 May 03, 2019	BUY	$69.58 - $79.36 $549,334 - $626,547	7,895 New	7,895 $657,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tap Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tap Consulting, LLC with notifications on news.

Account

Tap Consulting, LLC Merck & Co., Inc. Transaction History